ARorthopaedicGoniometer is an AR-based measurement tool for orthopaedic surgeons and physical therapists to calculate joint range of motion on iOS and Android.
The App DNA
What makes this app unique?
Clinicians hire this tool to replace cumbersome manual goniometers with a faster, digital-first workflow that documents patient progress via spatial 3D imagery.
For Orthopaedic surgeons, physicians, physical therapists, and veterinarians requiring quick, objective range-of-motion measurements in clinical settings.
What does it look like?
Key features
Calculates joint range of motion by placing 3D spheres on live camera imagery to define joint points. Revenue link: Core utility value proposition drives initial acquisition for clinical professionals.
Allows manual XYZ adjustment of the pointer tip sphere to improve placement accuracy in 3D space. Revenue link: Enhances measurement precision, reinforcing brand authority as a professional-grade clinical tool.
How much does it cost?
The iOS version utilizes a one-time purchase model at $6.99, positioning it as a low-cost alternative to expensive motion capture lab equipment.
Velocity
Steady developmentShow more...
5 versions in history. Development pace: steady.
Who built it?
ORTHOPRACTIS.COM SINGLE MEMBER P.C.
13+ apps tracked · Utilities
FemoroAcetabularImpingementApp
Dynamic3DFaceAsymmetryApp
SpinopelvicBalanceApp
SagittalBalanceApp
CenterEdgeAngleApp
CupAnteversionInclinationApp
AcetabularIndex
OsteotomyApp
DynamicGoniometerAR
NeckShaftAngle App
SpinopelvicMobilityApp
HipDysplasiaAppUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for ARorthopaedicGoniometer
How's the Utilities market?
The app maintains a presence in the Medical category across multiple global markets, though it faces high volatility in rank, often shifting by 50+ positions weekly. The $6.99 price point on iOS creates a significant barrier compared to the free native Measure utility.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for ARorthopaedicGoniometer
Where is it heading?
The market for clinical AR tools is consolidating around specialized professional workflows, yet ARorthopaedicGoniometer remains exposed to free native alternatives. The PM must shift focus toward institutional B2B distribution to insulate the app from the volatility of individual consumer chart rankings.
- High volatility in medical category rankings indicates unstable organic install velocity, which complicates long-term growth planning for the clinical tool.
- Recent updates focused on stability and minor corrections, suggesting the app is currently in maintenance mode rather than active feature expansion.
The SWOT
- Spatial pointer calibration enhances measurement precision in 3D space
- Sequential measurement retains points to reduce clinical time-per-patient
- Untapped B2B distribution through veterinary and physical therapy education partnerships
- Wearable integration could further differentiate from general-purpose AR tools
Next best moves
Pivot pricing strategy to a freemium model because the $6.99 barrier drives users to free native alternatives → increase top-of-funnel conversion.
+ 1 more prioritized moveThe counter-intuitive read
The app's volatility in medical category rankings is…
Read the full takeFeature gaps
System-level AR integration (available in Measure by Apple but absent here)
Since the last report: The report transitioned from a high-level overview to a detailed competitive analysis, clarifying the app's specific pricing, technical differentiators, and market threats.
Bottom line
ARorthopaedicGoniometer provides a specialized clinical workflow that manual tools cannot match, but its paid entry barrier against free native alternatives limits adoption, so the PM should prioritize B2B partnership channels to bypass the consumer-facing price friction.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated